NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Large Drop in Short Interest

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) saw a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 73,200 shares, a drop of 60.9% from the November 15th total of 187,000 shares. Based on an average trading volume of 2,760,000 shares, the days-to-cover ratio is presently 0.0 days.

NovaBay Pharmaceuticals Stock Performance

Shares of NBY stock traded up $0.02 on Thursday, reaching $0.56. The company’s stock had a trading volume of 122,792 shares, compared to its average volume of 921,268. The company has a market capitalization of $2.35 million, a PE ratio of -0.05 and a beta of 2.82. NovaBay Pharmaceuticals has a 12-month low of $0.36 and a 12-month high of $10.15.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.